The PKU mouse project: its history, potential and implications
McDonald, J. David
McDonald, J. David
Citations
Altmetric:
Authors
Other Names
Location
Time Period
Advisors
Original Date
Digitization Date
Issue Date
1994-12
Type
Article
Genre
Keywords
Subjects (LCSH)
Citation
Acta paediatrica (Oslo, Norway : 1992). Supplement. 1994 Dec; 407: 122-3.
Abstract
To produce genetic-based animal models for the human disease phenylketonuria (PKU), we treated mice with the powerful germline mutagen ethylnitrosourea and screened the progeny of these animals for the symptom hyperphenylalaninemia (HPH). Six independent mutant strains have been produced to date that exhibit heritable HPH. The first mutation isolated was found to cause a reduced level of GTP-cyclohydrolase I activity and, as such, yields a model for tetrahydrobiopterin-dependent HPH. The next two mutations have yet to be fully characterized but cause syndromes that appear distinct from any PKU or HPH syndromes yet reported for humans and they are allelic. Next we isolated a mutation that caused a marked reduction in hepatic phenylalanine hydroxylase activity levels. The enzyme deficiency was not sufficient to cause a PKU syndrome but instead produced a mild HPH syndrome. This strain played an instrumental role, however, in the identification of two additional mutant strains that appear to model human PKU very accurately in the laboratory mouse. These latter strains have levels of HPH very similar to human PKU patients, exhibit a phenylalanine-dependent hypopigmentation, and have reproductive difficulties that resemble human maternal PKU.
Table of Contents
Description
Click on the DOI link below to access the article (may not be free).
Publisher
Journal
Book Title
Series
Acta paediatrica (Oslo, Norway : 1992). Supplement
Digital Collection
Finding Aid URL
Use and Reproduction
Archival Collection
NLM
PubMed ID
DOI
ISSN
0803-5326